These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Changes in the business of culture. Pissarra Pde N Nat Biotechnol; 2004 Nov; 22(11):1355-6. PubMed ID: 15529153 [No Abstract] [Full Text] [Related]
4. Perspective: A tale of 'cautious pessimism': Biotechnology, recession and the 'new economy'. Kewell B; Webster A Biotechnol J; 2009 Aug; 4(8):1106-8. PubMed ID: 19685467 [No Abstract] [Full Text] [Related]
5. The changing norms of the life sciences. Shorett P; Rabinow P; Billings PR Nat Biotechnol; 2003 Feb; 21(2):123-5. PubMed ID: 12560827 [No Abstract] [Full Text] [Related]
6. Too little, too late: when is the right time for new leadership in biotech? Branthwaite P; Williams SJ Nat Biotechnol; 2004 Apr; 22(4):487-8. PubMed ID: 15034591 [No Abstract] [Full Text] [Related]
8. Perspective: Biotech funding trends: Insights from entrepreneurs and investors. Gruber AC Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460 [TBL] [Abstract][Full Text] [Related]
9. The development of China's medical biotech industry needs to be driven by innovation. Yu Z; Dai Y Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752 [TBL] [Abstract][Full Text] [Related]
18. Can China's supply of scientific talent keep up with demand? Wong G Nat Biotechnol; 2008 Feb; 26(2):243-4. PubMed ID: 18259182 [TBL] [Abstract][Full Text] [Related]